Posts for MEI Pharma, Inc. ($MEIP)

Explore MEI Pharma, Inc.'s Q4 2024 financial report, highlighting key insights, operational hurdles, and future growth potential. A thorough analysis for investors eyeing MEIP.

Discover critical information from MEI Pharma, Inc.'s 8-K filing on February 12, 2025. Key insights for investors on stock performance and significant corporate events.